Differentially expressed genes associated with the metastatic phenotype in breast cancer

Breast Cancer Research and Treatment

Volumn 55, Issue 2, 1999, Pages 127-136

  Kirschmann, Dawn A ^a   Seftor, Elisabeth A ^a   Nieva, Daniel R C ^a   Mariano, Elpidio A ^a   Hendrix, Mary J C ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Breast cancer; Differential display; Gene expression; Invasion; Metastasis

Indexed keywords

ANTIOXIDANT; KERATIN; PROTEIN LYSINE 6 OXIDASE; THIOL DERIVATIVE; THROMBOPLASTIN; TRANSCRIPTION FACTOR; VIMENTIN; ZINC FINGER PROTEIN;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GENETICS; CANCER INVASION; CELL STRAIN MCF 7; GENE EXPRESSION; HETEROCHROMATIN; HUMAN; HUMAN CELL; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; RNA ANALYSIS;

EID: 0032808432     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1006188129423     Document Type: Article

References (52)

1. Deville P, Schuuring E, van de Vijver MJ, Cornelisse CJ: Recent developments in the molecular genetic understanding of breast cancer. Crit Rev Oncogen 5: 247-270, 1994
2. Bieche I, Lidereau R: Genetic alterations in breast cancer. Genes Chrom Cancer 14: 227-251, 1995
3. Beckmann MW, Niederacher D, Schnurch HG, Gusterson BA, Bender HG: Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med 75: 429-439, 1997
4. Liang P, Averboukh L, Keyomarsi K, Sager R, Pardee AB: Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res 52: 6966-6968, 1992
5. Sager R, Anisowicz A, Neveu M, Liang P, Sotiropoulou G: Identification by differential display of alpha 6 integrin as a candidate tumor suppressor gene. FASEB J 7: 964-970, 1993
6. Lee SW, Tomasetto C, Sager R: Positive selection of candidate tumor suppressor genes by subtractive hybridization. Proc Natl Acad Sci USA 88: 2825-2829, 1991
7. Lee SW, Tomasetto C, Paul D, Keyomarsi K, Sager R: Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. J Cell Biol 118: 1213-1221, 1992
8. Lee SW, Tomasetto C, Swisshelm K, Keyomarsi K, Sager R: Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. Proc Natl Acad Sci USA 89: 2504-2508, 1992
9. Zou Z, Anisowicz A, Hendrix MJC, Thor A, Neveu M, Sheng S, Rafidi K, Seftor EA, Sager R: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263: 526-529, 1994
10. Sager R, Sheng S, Pemberton P, Hendrix MJC: Maspin: a tumor suppressing gene. In: Gunthert U, Birchmeier W (eds) Current Topics in Microbiology and Immunology; Attempts to Understand Metastasis Formation I, vol 213, Springer-Verlag, Berlin, 1996, pp 51-64
11. Liu X-L, Wazer DE, Watanabe K, Band V: Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res 56: 3371-3379, 1996
12. Watson MA, Fleming TP: Isolation of differentially expressed sequence tags from human breast cancer. Cancer Res 54: 4598-4602, 1994
13. Liu Z, Brattain MG, Appert H: Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435, versus the poorly invasive cell line, MCF-7. Biochem Biophys Res Commun 231: 283-289, 1997
14. Birchmeier C, Birchmeier W, Brand-Saberi B: Epithelial-mesenchymal transitions in cancer progression. Acta Anat 156: 217-226, 1996
15. Raymond WA, Leong AS-Y: Vimentin - a new prognostic parameter in breast carcinoma? J Pathol 158: 107-114, 1989
16. Domagala W, Wozniak L, Lasola J, Weber K, Osborn M: Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinoma. Am J Pathol 137: 1059-1064, 1990
17. Tomasino RM, Russo A, Bazan V, Morello V, Tralongo V, Nagar C, Salvato M, Taormina P, Marrazzo A, Nuara R, Vita C, Guddo F, Arena N, Bazan P: Evaluation of integrated morpho-biological indicators in breast cancer. In Vivo 7: 601-606, 1993
18. Koutselini H, Markopoulos CH, Lambropoulou S, Gogas H, Kandaraki CH, Gogas J: Relationship of epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and vimentin expression and various prognostic factors in breast cancer patients. Cytopath 6: 14-21, 1995
19. Athanassiadou P, Athanassiades P, Kyrkou K, Giahnaki E, Giannioti E, Nanas S: Expression of vimentin and epidermal growth factor receptor in effusions from patients with breast cancer; correlation with oestrogen and progesterone receptor status. Cytopath 4: 91-98, 1993
20. Sommers CL, Byers W, Thompson EW, Torn JA, Gelmann EP: Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 31: 325-335, 1994
21. Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donahue S, Lippman ME, Martin GR, Dickson RB: Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150: 534-544, 1992
22. Sommers CL, Walker-Jones D, Heckford SE, Worland P, Valverius E, Clark R, McCormick F, Stampfer M, Abularach S, Gelmann EP: Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells. Cancer Res 49: 4258-4263, 1989
23. Somers CL, Heckford SE, Skerker JM, Worland P, Torri JA, Thompson EW, Byers SW, Gelmann EP: Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines. Cancer Res 52: 5190-5197, 1992
24. Hendrix MJC, Seftor EA, Seftor REB, Trevor KT: Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am J Pathol 150: 483-495, 1997
25. Celano P, Vertino PM, Casero RA Jr: Isolation of polyadenylated RNA from cultured cells and intact tissues. Bio-Techniques 15: 28, 1993
26. Lennon GG, Auffray C, Polymeropoulos M, Soares MB: The I.M.A.G.E. consortium: an integrated molecular analysis of genomes and their expression. Genomics 33: 151-152, 1996
27. Scarpati EM, Wen D, Broze GJ Jr, Miletich JP, Flandermeyer RR, Siegel NR, Sadler JE: Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochem 26: 5234-5238, 1987
28. Pearson WR, Lipman DJ: Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 85: 2444-2448, 1988
29. Benson D, Lipman DJ, Ostell J: GenBank. Nucl Acid Res 63: 2963-2965, 1993
30. Hendrix MJC, Seftor EA, Seftor REB, Fidler IJ: A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. Cancer Lett 38: 137-147, 1987
31. Price JE, Polyzos A, Zhang RD, Daniels LM: Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 50: 717-721, 1990
32. Struhl K: Helix-turn-helix, zinc-finger, and leucine-zipper motifs for eukaryotic transcriptional regulatory proteins. TIBS 14: 137-140, 1989
33. Wallrath L: Unfolding the mysteries of heterochromatin. Curr Opin Gen Dev 8: 147-153, 1998
34. Williams TM, Moolten D, Burlein J, Romano J, Bhaerman R, Godillot A, Mellon M, Rauscher FJ, Kant JA: Identification of a zinc finger protein that inhibits IL-2 gene expression. Science 254: 1791-1794, 1991
35. Wantanabe Y, Kawakami K, Hirayama Y, Nagano K: Transcription factors positively and negatively regulating the Na,K-ATPase alpha 1 subunit gene. J Biochem 114: 849-855, 1993
36. Genetta T, Ruezinsky D, Kadesch T: Displacement of an E-box-binding repressor by basic helix-loop-helix proteins: Implications for B-cell specificity of the immunoglobulin heavy-chain enhancer. Mol Cell Biol 14: 6153-6163, 1994
37. Sekido R, Takagi T, Okanami M, Moribe H, Yamamura M, Higashi Y, Kondoh H: Organization of the gene encoding transcriptional repressor deltaEFl and crossspecies conservation of its domains. Gene 173: 227-232, 1996
38. Ikeda K, Kawakami K: DNA binding through distinct domains of zinc-finger-homeodomain protein AREB6 has different effects on gene transcription. Eur J Biochem 233: 73-82, 1995
39. Vershon AK: Protein interactions of homeodomain proteins. Curr Opin Biotech 7: 392-396, 1996
40. Castronovo V, Kusaka M, Chariot A, Gielen J, Sobel M: Homeobox genes: potential candidates for the transcriptional control of the transformed and invasive phenotype. Biochem Pharm 47: 137-143, 1994
41. Tommerup N, Vissing H: Isolation and fine mapping of 16 novel human zinc finger-encoding cDNAs identify putative candidate genes for developmental and malignant disorders. Genomics 27: 259-264, 1995
42. Sugimoto K, Yamada T, Muro Y, Himeno M: Human homolog of Drosophila heterochromatin-associated protein 1 (HP1) is a DNA-binding protein which possesses a DNA-hinding motif with weak similarity to that of human centromere protein C (CENP-C). J Biochem 120: 153-159, 1996
43. Powers JA, Eissenherg JC: Overlapping domains of the heterochromatin-associated protein HP1 mediate nuclear localization and heterochromatin binding. J Cell Biol 120: 291-299, 1993
44. Eissenberg JC, Morris GD, Reuter G, Hartnett T: The heterochromatin-associated protein HP-1 is an essential protein in Drosophila with dosage-dependent effects on position-effect variegation. Genetics 131: 345-352, 1992
45. Kagan HM, Trackman PC: Properties and function of lysyl oxidase. Am J Respir Cell Mol Biol 5: 206-210, 1991
46. Kuivaniemi H, Korhonen R-M, Vaheri A, Kivirikko KI: Deficient production of lysyl oxidase in cultures of malignantly transformed human cells. FEBS Lett 195: 261-264, 1986
47. Hamalainen E-R, Kemppainen R, Kuivaniemi H, Tromp G, Vaheri A, Pihlajaniemi T, Kivirikko KI: Quantitative polymerase chain reaction of lysyl oxidase mRNA in malignantly transformed human cell lines demonstrates that their low lysyl oxidase activity is due to low quantities of its mRNA and low levels of transcription of the respective gene. J Biol Chem 270: 21590-21593, 1995
48. Contente S, Kenyon K, Rimoldi D, Friedman RM: Expression of gene rrg is associated with reversion of NTH 3T3 transformed by LTR-c-H-ras. Science 249: 796-798, 1990
49. Peyrol S, Raccurt M, Gerard F, Gleyzal C, Grimaud JA, Sommer P: Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma. Am J Pathol 150: 497-507, 1997
50. Wakasaki H, Ooshima A: Immunohistochemical localization of lysyl oxidase with monoclonal antibodies. Lab Invest 63: 377-384, 1990
51. Lazarus HM, Cruickshank WW, Narasimhan N, Kagan HM, Center DM: Induction of human monocyte motility by lysyl oxidase. Matrix Biol 14: 727-731, 1994
52. Casey ML, MacDonald PC: Lysyl oxidase (ras recision gene) expression in human amnion: ontogeny and cellular localization. J Clin Endocrin Metab 82: 167-1772, 1997